Alexander Vartanov is an Oncology physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 45 publications with 2,824 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
333 Cottman Ave
Philadelphia, PA 191112434
Telephone
215-728-2570Provider last certified this registry record 6 Sept 2024.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20242 payments
- Daiichi Sankyo Inc.Program year20241 payment
- Astellas Pharma US IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
33.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor33.1%Acyclovir100%Part D<11 patientsNervous system
27.1%Gabapentinoids27.1%Gabapentin100%Part D<11 patientsHormonal (systemic)
13.5%l-Thyroxine13.5%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparable High-Grade Toxicity with Axi-Cel Plus Dexamethasone Prophylaxis Versus Liso-Cel: A Real-World Analysis
Biology of Blood and Marrow Transplantation
2026 - Efficacy of Allogenic Stem Cell Transplant in KMT2A Partial Tandem Duplication (KMT2A-PTD) Myeloid Neoplasms
Biology of Blood and Marrow Transplantation
2026 - Outcomes of Geriatric Patients Receiving CD19 Directed CAR-T Therapy: A Single Institution Study
Biology of Blood and Marrow Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Elizabeth Plimack, MD
Fox Chase Cancer Center
Robert Uzzo, MD02041967
Fox Chase Cancer Center
John Ridge, MD
Fox Chase Cancer Center
Eric Horwitz, MD
Fox Chase Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”